ePrints

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

Lookup NU author(s): Professor Tiago OuteiroORCiD

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Abstract

© 2021, The Author(s).With the advent of the genetic era in Parkinson’s disease (PD) research in 1997, α-synuclein was identified as an important player in a complex neurodegenerative disease that affects >10 million people worldwide. PD has been estimated to have an economic impact of $51.9 billion in the US alone. Since the initial association with PD, hundreds of researchers have contributed to elucidating the functions of α-synuclein in normal and pathological states, and these remain critical areas for continued research. With this position paper the authors strive to achieve two goals: first, to succinctly summarize the critical features that define α-synuclein’s varied roles, as they are known today; and second, to identify the most pressing knowledge gaps and delineate a multipronged strategy for future research with the goal of enabling therapies to stop or slow disease progression in PD.

Publication metadata

Author(s): Oliveira LMA, Gasser T, Edwards R, Zweckstetter M, Melki R, Stefanis L, Lashuel HA, Sulzer D, Vekrellis K, Halliday GM, Tomlinson JJ, Schlossmacher M, Jensen PH, Schulze-Hentrich J, Riess O, Hirst WD, El-Agnaf O, Mollenhauer B, Lansbury P, Outeiro TF

Publication type: Review

Publication status: Published

Journal: npj Parkinson's Disease

Year: 2021

Volume: 7

Issue: 1

Online publication date: 26/07/2021

Acceptance date: 14/05/2021

ISSN (electronic): 2373-8057

Publisher: Nature Research

URL: https://doi.org/10.1038/s41531-021-00203-9

DOI: 10.1038/s41531-021-00203-9

Share